All In Biotech

Free tool

FAERS Monitor: Istalol

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021516 or its brand name (Istalol, Timolol Maleate). Reports on generic versions are filed under their own applications.

Reports

7,905

Serious

3,740

47% of reports

Hospitalization

1,571

Death reported

443

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • treatment failure982
  • drug ineffective588
  • eye pain453
  • fatigue421
  • eye irritation374
  • dizziness299
  • diarrhoea293
  • vision blurred271
  • nausea268
  • off label use267
  • headache257
  • dyspnoea242
  • intraocular pressure increased236
  • ocular hyperaemia234
  • death229

Reports by year received

View as table
YearReports
2004158
2005194
2006157
2007144
2008136
2009141
2010210
2011222
2012330
2013122
2014147
2015259
2016314
2017351
2018370
2019408
20201,444
2021417
2022440
2023514
2024518
2025558
2026350

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,254 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
intraocular pressure increasedSignal23650.044.111,091
treatment failureSignal98231.930.129,133
eye painSignal45321.519.78,799
eye irritationSignal37417.415.85,741
ocular hyperaemiaSignal23413.211.62,614
vision blurredSignal2715.34.7935
dizziness2991.61.467
fatigue4211.41.358
diarrhoea2931.21.111
drug ineffective5881.21.118
dyspnoea2421.11.04
headache2571.11.02
nausea2680.90.83
off label use2670.80.712
death2290.70.629

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.